__________________________________________________________________

  A. TUMOR IMMUNE INFILTRATES
__________________________________________________________________

Lecture:
  - Immune cells and tumor infiltrating lymphocytes: types, functional orientation, and relevance for cancer
  - Estimating tumor infiltrating immune cells from expression data: GSEA, deconvolution, ESTIMATE,...
  - Example algorithms for deconvolution: how do they work in practice?
  - Brief introduction on NGS expression data (i.e. RNA-seq): TPM, counts, RPKM, FPKM

# Ex. A1 (slides): deconvolution of RNA-seq data with a web-service
# Data: Hoek et. al, 2015?
# Method: CIBERSORT web-service
  - Understanding input data: introduction to LM22 signature matrix and immune cell-types
  - Possible data issues: overlap mixture/signature genes, annotation, Excel format issues, data format
  - Running the analysis: options
  - Understanding the results: output data format
  [ Save deconvolution results in shared folder ]
  
# Ex. A2 (hands-on): deconvolution of RNA-seq in R 
# Data: Hoek et. al, 2015?
# Method: DeconRNAseq+LM22?
  - Understanding the effect of data normalization: natural and log-scale
  - Understanding the collinearity issue
  - Benchmarking deconvolution results with flow cytometry: correlation and RMSE
  - Comparing results between methods
  
# Ex. A3 (hands-on): deconvolution of tumor RNA-seq data in R
# Data: TCGA CRC
# Method: DeconRNAseq+LM22?
  - Preparing input data for deconvolution
  - Running deconvolution in R: options
  - Example application on TCGA data: tumor-infiltrating immune cells in CRC molecular subgroups (MSS vs. MSI)
 
# Ex. A4 (hands-on): quantification of tumor infiltrating lymphocytes from tumor RNA-seq data in R
# Data: TCGA CRC
# Method: ESTIMATE
  - Selecting/preparing input data: which data should be used? What is TPM normalization effect on rankings?
  - Running ESTIMATE: parameters
  - Interpreting ESTIMATE scores
  - Example application on TCGA data: immune scores of CRC molecular subgroups (MSS vs. MSI)
  
  
__________________________________________________________________

  B. TUMOR ANTIGENS
__________________________________________________________________

Lectures: 
  - The tumor-immunity cycle and the anticancer immune response
  - The different steps of antigen processing and presentations  
  - The different types of tumor antigens and their specificity
  - Pipelines and tools for the prediction of tumor neo-antigens from NGS data
  - Human MHC: HLAs and HLA-typing at 4-digit resolution
  - Brief introduction on mutational data: VCF format
  - Brief introduction on sequence data fromat (RNA-seq reads, genome, protein): FASTQ, FASTA
  
# Ex. B1 (hands-on): quantification of cancer-germline-antigen expression from tumor RNA-seq data [ Maybeâ€¦ ]
# Data: TCGA CRC
# Method: heatmap, CTdtabase, databases for normal tissues
 - Assess the expression of cancer-germline antigens (CGAs) listed in the CTdtabase
 - Specificity of CGA expression: issues with expression in normal tissues (databases)

# Ex. B2 (slides): annotation of somatic mutations to predict mutated proteins
# Data: single-sample tumor data (VCF) on selected mutations
# Method: VEP web-service
 - Run VEP: parameters and plugings (mutated proteins, Condel score)
 - Output data format: extracting the mutated proteins
 - Extract mutated peptides from mutated proteins (R code?)
 [ Save deconvolution results in shared folder ]

# Ex. B3 (hands-on, if possibl): prediction of HLA-types from RNA-seq data
# Data: SMALL RNA-seq data from single-sample (TIminer)
# Method: Optitype @TIminer
 - Running Optitype: input (DNA/RNA) and parameters 
 - Interpreting results: output data format and 4-digit resolution
 [ Save deconvolution results in shared folder ]

# Ex. B4 (hands-on): prediction of HLA-peptide binding affinity
# Data: few examples peptides from B2, HLAs from B3
# Method: Optitype @TIminer
- Preparing input data
- Interpreting results: ranks and binding affinity

# Ex. B5 (hands-on, if possible): prediction of tumor neo-antigens from single-patient mutational and RNA-seq data
# Data: TCGA SKCM?
# Method: TIminer?
- Run the full pipeline on single-sample data, also with expression filtering
- Interpreting the results
- Discuss the importance of neo-antigens prioritization (examples from personalized vaccination)

